← Back to Search

Omega-3 Fatty Acid Supplement

Omega 3 Supplementation for Pregnancy (TOTS Trial)

N/A
Recruiting
Led By Teri L Hernandez, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 34 weeks gestational age
Awards & highlights

TOTS Trial Summary

This trial plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are ~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid

TOTS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~34 weeks gestational age
This trial's timeline: 3 weeks for screening, Varies for treatment, and 34 weeks gestational age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maternal Fasting and Postprandial Triglycerides

TOTS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Omega 3 SupplementationExperimental Treatment1 Intervention
Supplementation of 4g of DHA/EPA daily
Group II: Safflower Oil SupplementPlacebo Group1 Intervention
Supplementation of Safflower Oil daily

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,749 Previous Clinical Trials
2,164,020 Total Patients Enrolled
University of OklahomaOTHER
455 Previous Clinical Trials
95,616 Total Patients Enrolled
Teri L Hernandez, PhDPrincipal InvestigatorUniversity of Colorado - Anschutz Medical Campus

Media Library

Intervention Omega 3 Supplementation (Omega-3 Fatty Acid Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04349475 — N/A
Pregnancy Research Study Groups: Safflower Oil Supplement, Omega 3 Supplementation
Pregnancy Clinical Trial 2023: Intervention Omega 3 Supplementation Highlights & Side Effects. Trial Name: NCT04349475 — N/A
Intervention Omega 3 Supplementation (Omega-3 Fatty Acid Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04349475 — N/A
~11 spots leftby May 2025